about
Current concepts in the immunohistochemical evaluation of liver tumorsFibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular CarcinomaGenomic analysis of fibrolamellar hepatocellular carcinoma.Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features.Molecular pathology of hepatic neoplasms: classification and clinical significance.Hepatocellular carcinoma with both fibrolamellar and classical components: an unusual morphological pattern.Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cellsHepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.Fibrolamellar carcinoma: 2012 updateOncocytic mania: a review of oncocytic lesions throughout the body.Comprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.Immunohistochemical evaluation of a sarcomatoid hepatocellular carcinoma with osteoclastlike giant cells.FGFR1 and FGFR2 in fibrolamellar carcinoma.Combined hepatocellular carcinoma and fibrolamellar carcinoma presenting as two adjacent separate lesions in a young boy: first case report from Asia.Molecular testing for the clinical diagnosis of fibrolamellar carcinoma.Transcriptional profiling of pure fibrolamellar hepatocellular carcinoma reveals an endocrine signature.Fibrolamellar Carcinoma in the Carney Complex: PRKAR1A Loss Instead of the Classic DNAJB1-PRKACA Fusion.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Intracranial metastasis in fibrolamellar hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.Environmental exposures as a risk factor for fibrolamellar carcinoma.mTORC1 and FGFR1 signaling in fibrolamellar hepatocellular carcinoma.Utility of Cytokeratin7 Immunocytochemistry in the Cytopathological Diagnosis of Fibrolamellar Hepatocellular Carcinoma.
P2860
Q26864205-C43D92B9-6E56-4D80-B534-8B3F1D24CD74Q28072292-B2E8D8CA-E7AD-48BE-9F4E-E232B7F23C11Q34673400-D294D978-FDB8-4B69-9358-B511B5FF3683Q34703712-4607F10B-311A-44FF-AB89-BE1D54AD9B96Q34954493-E670EEA3-692B-4C98-A45A-C0D449EA2D68Q35169728-507765F1-03D9-4B01-99FB-47F582C1C7B4Q36145871-43B9E520-030C-4FC1-8D85-7E8C9BD7E501Q36731897-44D2245D-EE9E-46E2-A438-FF9DF4E67306Q37288706-878EFEC1-63C8-438A-AC6A-C2676CC753CAQ37837353-1A58CE0E-6870-40C3-BCC9-95F9C3EAED4EQ38901483-6289CF9E-AFAC-4D0D-970D-C064221EEA54Q39889043-50FAE46E-1946-4FFD-A2E4-23AC560DC720Q40002185-48053DA3-C91A-42C3-8809-0C521B9B9ECEQ40640497-4A53AD61-D426-4A58-AA72-A9B387657DD9Q42959728-1198BBE7-4B91-4775-B505-5688E9CD1675Q46447893-630DEF35-584D-4EC9-B42E-CCDAAF0FAD4BQ46688979-EF254006-BF15-4187-9127-216727987C75Q47312923-1EF8BD21-1224-4419-B895-4C5B8D33D7E0Q47377422-20BA0F69-21F6-47E3-B34F-CE70B9F2708BQ47635386-3313486C-8C8F-4F96-8439-A7769AA80B0FQ47891035-7596CCD2-303C-4963-B50F-A9746FF2E018Q52689575-62AC9052-352D-44CF-AB7C-FF46315A3959Q52897650-2C57FB57-896E-4F12-8052-A0534BC83E61Q54345071-10F793E8-1E84-471C-A720-0C0671F29C47Q55000321-5FD03F94-8D73-464F-89A5-9305C14F5242
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Fibrolamellar carcinomas are positive for CD68
@ast
Fibrolamellar carcinomas are positive for CD68
@en
type
label
Fibrolamellar carcinomas are positive for CD68
@ast
Fibrolamellar carcinomas are positive for CD68
@en
prefLabel
Fibrolamellar carcinomas are positive for CD68
@ast
Fibrolamellar carcinomas are positive for CD68
@en
P2093
P2860
P1433
P1476
Fibrolamellar carcinomas are positive for CD68
@en
P2093
Hala R Makhlouf
Hillary M Ross
Hubert D J Daniel
Matthew M Yeh
Michael Torbenson
Perumal Vivekanandan
Rajesh Kannangai
Tsung-Teh Wu
P2860
P2888
P304
P356
10.1038/MODPATHOL.2010.207
P577
2010-11-26T00:00:00Z
P5875
P6179
1029936537